The record
| Class | mitochondrial |
|---|---|
| Also known as | - |
| Chain length | - |
| Molecular weight | 2,174.59 Da |
| Half-life | 2-4 hours |
| Route | - |
| Studied for | - |
| Research use | - |
| What has been shown | - |
| How it works | AMPK activation; Insulin sensitization; Metabolic regulation |
| Patent status | - |
| Regulatory status | - |
Blank = not established in the record. Nothing is estimated to fill a gap.
Where it is matched
- Fat Loss Signaling Environment (affection, 31%)
- Glucose Regulation Support (affection, 38%)
- Mitochondrial Efficiency / Energy Signaling (affection, 81%)
- Cardiovascular risk reduction in T2DM (illness, 30%)
- Fat loss without muscle loss (illness, 30%)
- NASH/fatty liver (illness, 30%)
- Type 2 diabetes mellitus (illness, 30%)
- Weight management (illness, 30%)
- Fatigue or low energy (symptom, 67%)
- High blood sugar (symptom, 50%)